跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Engerix B - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Engerix B
Approved
STANDARD
Engerix B
GlaxoSmithKline Biologicals SA
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d5a4994d1c44fec2
Company
GlaxoSmithKline Biologicals SA
Type
Standard
Approval Details
Approval Id
d5a4994d1c44fec2
Drug Approval Philippines Name
Engerix B
Product Name
Engerix B
Registration Number
BR-744
Brand Name
Engerix B
Generic Name
Recombinant Hepatitis B Vaccine
Dosage Form
Suspension for Injection (IM)-Thiomersal Free
Dosage Strength
20 mcg/mL
Manufacturer
GlaxoSmithKline Biologicals SA
Importer
GlaxoSmithKline Philippines, Inc.
Company Detail Path
/organization/glaxosmithkline-biologicals-sa
Issuance Date
28 June 2024
Expiry Date
28 June 2029
Pharmacologic Category
Vaccine
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d5a4994d1c44fec2
Type
Standard
Back to Philippines FDA Approvals